The Pioneering Visionaries Behind JuveXO®

Brian Pla's journey from the finance sector to the forefront of regenerative medicine and biocosmetics illustrates his adept transition and entrepreneurial spirit.
Initially making his mark in finance and co-founding a foreign currency trading firm, Pla's subsequent venture into the medical field was sparked by his personal experience with cell-based therapies. This shift led him to introduce new approaches in precision medicine and cell-based treatments, contributing to advancements in non-invasive and minimally invasive procedures. In 2017, he founded Gentera Centers for Precision Medicine and Plastic Surgery, focusing on personalized care and precision medicine, guiding Gentera to become a recognized name in regenerative medicine.

Furthering his impact, Pla played a pivotal role in creating Eternus Biosciences through his collaboration with TheBioBox, launching the exosome product JuveXO®.This product has since gained recognition among physicians globally and is poised for expansion into the retail cosmetic market. His recent appointment as President of Congela Biocosmetics, post-acquisition of JuveXO®, reflects his ongoing commitment to advancing biocosmetic products, particularly in the realm of regenerative hair and skin products.

Pla's commitment is also evident in Coral Gables, Florida, where Gentera Center for Precision Medicine offers a new perspective on preventive medicine and cellular therapies. Motivated by his own health journey, Pla advocates for a health-focused lifestyle, emphasizing prevention over treatment. Beyond the US to Rehealth in Cancun MX, where he continues to lead a skilled team that is focused on developing treatments using advanced cell therapies. Pla's role in developing JuveXO® and his leadership at Congela Biocosmetics mark him as a significant figure in regenerative medicine and the emerging BioCosmetics sector, blending health and beauty through innovative approaches.

Dr Gonzalez obtained his Ph. D and BS from the University of California, Irvine where he studied, and his thesis addressed interactions of the immune system following spinal cord injury. In addition to his expertise in degenerative disorders involving the spinal cord, he has extensive experience in stem cell culture and biology from various tissue sources.

Dr. Gonzalez has always had a passion to assist those suffering from age related diseases, from bench to bedside (translational therapeutics), and allow them to live a normal life. These pursuits drive Dr. Gonzalez to affordably scale promising developments to the masses. He is responsible for the development of clinical stem cell applications for several disease/trauma states. He leads multiple investigational new drug applications with patented stem cell technology, and also works on the clinical development of immune based therapies using natural killer cells. Through the American Academy of Antiaging, his lectures on age related disorders and the role of the immune system and cell therapeutics to aid in maintaining health are well known. Dr Gonzalez is well published and respected in the regenerative medicine sector for his ability in understanding all aspects of cell-based therapeutics and their clinical applicability.

Damon Sementilli serves as Vice President of Operations at JuveXO®, where he leads operational strategy, supply-chain execution, and commercial scalability across the company’s advanced regenerative and exosome-derived platforms. Over the course of nearly two decades, Damon has built deep expertise at the intersection of biotech, functional ingredients, fragrance, and prestige beauty. He previously served as Vice President of a fragrance and functional ingredient company supporting the personal care and beauty industries, where he worked with hundreds of global and emerging brands on ingredient-led marketing campaigns and thousands of perfumery submissions across fine fragrance and personal care briefs. Throughout his career, Damon has collaborated with leading multinational organizations including Procter & Gamble, L’Oréal, and Unilever, as well as numerous high-growth startups, helping translate technical innovation into commercially successful products. He is also the Founder and former President of Beauty Brand Alchemist, a consultancy focused on brand strategy, ingredient storytelling, and go-to-market execution for beauty and wellness brands. Damon holds a business degree from the University of Louisville and is a Lean Six Sigma Black Belt, bringing a disciplined, data-driven approach to operational excellence and continuous improvement. At JuveXO®, Damon applies his combined operational, scientific, and commercial experience to scale cutting-edge technologies with rigor, compliance, and long-term brand value.

Sylvia, VP of Growth and Strategy at Congela Biocosmetics, is a seasoned leader with a proven track record spanning the U.S., Latin America, and Europe. With over two decades of experience in Marketing, Business Development, and Strategic Ideation, she excels in driving transformation across diverse sectors. Sylvia’s focus is to solidify Congela’s brand as the leader in cell-derived beauty and launch new products that will undoubtedly transform the aesthetics landscape. Previously serving as Director of Business Acquisition and Digital Transformation at Abbott Laboratories for the Latin American Region, Sylvia played a pivotal role in shaping strategies for growth. In 2020, she also co-founded a healthcare start-up focused on COVID Testing and spearheaded numerous global partnerships. Sylvia holds an Executive MBA from Northwestern’s Kellogg School of Business Management and a Bachelor’s in Communications from the University of Miami.